Author

Michael Timonian

Observed name: Michael A. Timonian

Institutions: Broad Institute, Harvard University, St. Mary Medical Center, Dana-Farber Cancer Institute

Observed institutions: Broad Institute, Harvard University, St. Mary Medical Center, Dana-Farber Cancer Institute

ORCID: 0000-0002-1014-3502

Observed ORCID: 0000-0002-1014-3502

OpenAlex ID: A5014426544

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

2025 · Omar Nadeem, Michelle P. Aranha, et al. · Nature Communications · 20

PDF

Enhanced dynamic risk stratification of smoldering multiple myeloma

2026 · Floris Chabrun, Daniel E. Schwartz, et al. · Nature Medicine · 7

PDF

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

2024 · Omar Nadeem, Michelle P. Aranha, et al. · medRxiv · 6

PDF

Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in 365 Patients with MGUS and SMM Demonstrates Complex Progressive Changes in Immune Cell Functionality with a Distinct Footprint on Tumor Cell Biology and Disease Control

2024 · Romanos Sklavenitis-Pistofidis, Ting Wu, et al. · Blood · 3

PDF

Improved Risk Stratification of Smoldering Multiple Myeloma (SMM) Using Trajectory Data in the Pangea 2.0 Model: A Multicenter Study in 1,431 Participants

2024 · Floris Chabrun, Daniel Schwartz, et al. · Blood · 2

PDF

Invasive Urothelial Carcinoma Presenting With Combined Obstructive Uropathy and Ischemic Small- and Large-Bowel Obstruction

2026 · Gagik Gabrielyan, Michael Timonian, et al. · Cureus

Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study

2026 · Irene Ghobrial, Noe Perron, et al. · Research Square

PDF

Single-cell immune profiling reveals enhanced immune fitness of endogenous and engineered T cells in patients with high-risk smoldering myeloma compared to Relapsed/Refractory myeloma following bispecific antibodies or CAR-T cell therapies.

2025 · Francesco Corrado, Nayda Bidikian, et al. · Blood

PDF

Monoclonal Gammopathy of Indeterminate Potential (MGIP) as an Early and Premalignant Stage in the Evolution Toward Hematological Malignancies

2025 · Sungjae Kim, Sabine Allam, et al. · Clinical Lymphoma Myeloma & Leukemia

Tumor-Intrinsic and Immune Predictors of Response to Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

2024 · Michelle P. Aranha, Omar Nadeem, et al. · Blood

PDF

Longitudinal Single-Cell Immune Profiling Reveals Distinct Dynamics of Response to Teclistamab in Patients with High-Risk Smoldering Myeloma Compared to Relapsed-Refractory Multiple Myeloma

2024 · Nayda Bidikian, Francesco Corrado, et al. · Blood

Deep Learning Unveils Characteristics of Immune B Cell Aging in >17,000 Samples and Identifies Changes in the Immunoglobulin Repertoire Distribution and the Development of Monoclonal Gammopathy

2024 · Floris Chabrun, Jean-Baptiste Alberge, et al. · Blood

PDF

OA-42 Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in Patients With Plasma Cell Premalignancy Unveils Co-Regulation of Disease Progression by Tumor Biology and Immune Dysregulation

2024 · Romanos Sklavenitis-Pistofidis, Ting Wu, et al. · Clinical Lymphoma Myeloma & Leukemia

Large-Scale Characterization and Functional Assessment of Adaptive Immunity in Patients with MGUS and SMM Reveals Significant Defects

2023 · Michelle P. Aranha, Romanos Sklavenitis-Pistofidis, et al. · Blood

PDF

P-411 Large-scale single-cell dissection of immune dysregulation in patients with monoclonal gammopathies

2023 · Romanos Sklavenitis-Pistofidis, Ting Wu, et al. · Clinical Lymphoma Myeloma & Leukemia

P-096 Real world evidence of suboptimal humoral and cellular immune response to vaccination in ostensibly asymptomatic patients with precursor stage of multiple myeloma

2023 · Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, et al. · Clinical Lymphoma Myeloma & Leukemia

Abstract 796: Altered immune response to vaccination in patients with plasma cell premalignancy

2023 · Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, et al. · Cancer Research

Single-Cell RNA-Sequencing of 370 Bone Marrow and Peripheral Blood Immune Cell Samples from Patients with MGUS and Smoldering Multiple Myeloma Reveal Significant Immune Dysregulation at the MGUS Stage, and Novel Interactions between Tumor and Immune Cells

2022 · Romanos Sklavenitis-Pistofidis, Ting Wu, et al. · Blood

Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM

2022 · Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, et al. · Blood

Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies

2022 · Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, et al. · Cancer Research

Works count: 20

Citation count: 38

H-index: 3

I10-index: 1